Stanford Medcast Episode 5: COVID-19 Mini-series - Immunomodulators Under Evaluation
Stanford University via Independent
-
34
-
- Write review
Live Online Classes in Design, Coding & AI — Small Classes, Free Retakes
Lead AI Strategy with UCSB's Agentic AI Program — Microsoft Certified
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Stanford Center for Continuing Medical Education, Stanford Medcast Episode 5: COVID-19 Mini-series - Immunomodulators Under Evaluation, 10/20/2020 12:00:00 AM - 10/20/2023 12:00:00 AM, This episode will provide up to date insights about COVID-19 and treatments that target inflammation. Dr. Anne Liu will address the risk and benefits of using immunomodulators and when to use them based on the disease state of the patient. Listen in to learn how to treat patients early in the disease process with antivirals, and which immunomodulators are better and more cost effective for later stage disease.